MAIA Biotechnology (MAIA) Stock: Buy, Sell, or Hold?
MAIA - MAIA Biotechnology, Inc.
$1.19
0.00 (0.00%)
▲
5d:
+0.85%
30d:
-10.53%
90d:
-19.05%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 06, 2026
Get Alerted When MAIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MAIA is fairly valued with market pricing in 3.8% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: MAIA is fairly valued with market pricing in 3.8% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.56
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.97
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MAIA is currently trading at $1.19, which is considered oversold relative to its 30-day fair value range of $1.22 to $1.37. The stock's valuation (Forward PE: 1.1) is in line with its historical norms (1.0). At these levels, the market is pricing in 3.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.15, while resistance sits at $1.37.
Market Sentiment: MAIA scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.00 (+908.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.15, while resistance sits at $1.37.
Market Sentiment: MAIA scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.00 (+908.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.22 -
$1.37
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
91.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (69/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 908.4% below Wall St target ($12.00)
- NEUTRAL: Market pricing in 3.8% annual earnings growth - fairly valued
- CAUTION: Bottoming setup, but lagging the sector by 21% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.22 -
$1.37
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.15
Resistance Level
$1.37
Current Trend
Strong Downtrend
Technical data as of
Oct 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.07
Wall Street Target
$12.00
(+908.4%)
Valuation Premium vs History
+3.8% premium
PE vs Historical
1.1 vs 1.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.8%
(market-implied from PE analysis)
1-Year Target
$1.24
(+4%)
2-Year Target
$1.28
(+8%)
3-Year Target
$1.33
(+12%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
PE COMPRESSION
$1.24
(+4%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 05, 2026 2:32 PM ET
Data refreshes hourly during market hours. Next update: 3:32 PM
Data refreshes hourly during market hours. Next update: 3:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAIA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 56 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
19 analysts |
$18 | 53 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 48 HOLD |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$28 | 64 BUY |
|
ZYME
Zymeworks Inc. Common St… |
STRONG BUY
14 analysts |
$41 | 56 HOLD |
